Novo Nordisk slashing price of Wegovy to $499 a month to uninsured following rival’s move
The Food and Drug Administration in February removed Wegovy from its shortage list and told compounders to cease selling their cheaper copies in the coming months, having removed Zepbound in December.
Novo Nordisk slashes Wegovy price for patients lacking insurance benefits
Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who can’t get the blockbuster drug through insurance.
Yahoo Finance1mon
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's NOVOb.CO popular weight-loss and diabetes drugs, Wegovy and Ozempic ...